AVMA news
Monoclonal antibodies show promise as new therapy for veterinary patients
More than 100 monoclonal antibodies (mAb) designed to bind to specific target proteins are available for humans, including those intended to treat…
blog
Congressional offices consider making xylazine a controlled substance
With illicit xylazine increasingly showing up in street drugs that pose grave risks to human users, government policymakers are discussing making it a…
AVMA news
New law clarifies alternatives to animal testing for safety, efficacy of drugs
The recently passed FDA Modernization Act 2.0 authorizes the use of certain alternatives to animal testing, including cell-based assays and computer…
AVMA news
Panel takes One Health approach to combating antimicrobial resistance
The executive director of the Presidential Advisory Council on Combating Antibiotic-Resistant Bacteria (PACCARB) briefed the AVMA House of Delegates…
AVMA news
FDA warns manufacturers, distributors of unapproved antimicrobials for animals
The U.S. Food and Drug Administration (FDA) on December 14 announced it has issued nine warning letters to manufacturers and distributors of…
policy
WVA position statement on use of horses for production of biologics and therapeutics
The AVMA endorses this position statement developed by the World Veterinary Association (WVA) on the use of horses for production of biologics and…
AVMA news
North Carolina law will require veterinarians to report gabapentin use
As part of Governor Roy Cooper’s North Carolina Opioid Action Plan, a new law will require the state’s veterinarians to report the use of gabapentin…
AVMA news
FDA releases updated plan for antimicrobial stewardship in veterinary settings
The U.S. Food and Drug Administration’s Center for Veterinary Medicine on October 1 launched the latest phases of its ongoing plan to promote…
AVMA news
FDA creates guidance on informed consent for companion animal studies
The U.S. Food and Drug Administration (FDA) has announced draft guidance that will help animal owners who are considering having their companion…
AVMA news
AVMA webinars help veterinarians navigate opioid epidemic
Three new drug-related webinars are available on demand on AVMA Axon to help veterinarians meet their state’s continuing education (CE) requirements…
AVMA applauds passage of legislation to enhance the review process of new and generic animal drugs
In the latest government spending bill, Congress included and passed legislation that reauthorizes the Animal Drug User Fee Act (ADUFA) and the Animal…
AVMA news
Addressing global inequities in access to essential medicines
The World Veterinary Association (WVA) and the World Small Animal Veterinary Association (WSAVA) are taking steps to improve the global availability…
AVMA news
Claims about meat, poultry products come under greater USDA scrutiny
The U.S. Department of Agriculture is stepping up efforts to ensure the veracity of claims about food animal products marketed as "free range" and…
AVMA news
New drug calms cats during transportation, veterinary visits
The Food and Drug Administration (FDA) this November approved Bonqat, a nerve pain medication for cats to alleviate acute anxiety and fear associated…
AVMA news
Shortage of cancer drugs having devastating effects on patients, veterinarians
Chemotherapy drugs, including cisplatin and carboplatin, have been in short supply for months. The situation is affecting animal patients and…
blog
AVMA endorses federal legislation to address illicit xylazine
The bill would equip law enforcement with additional tools to stop illegal xylazine trafficking while protecting veterinarians’ access to this…
AVMA news
FDA: Congress, not rule-making, likely route for CBD availability
With the cannabidiol products market continuing to grow and after reviewing published scientific literature and information submitted to a public…
AVMA news
Sales, distribution of medically important antimicrobials remain down for food animals
Annual sales and distribution by volume of medically important antimicrobials for food-producing animals remain down since the substantial decrease in…
AVMA news
Telehealth bill advances in California Senate
California Assembly Bill 1399 passed the California Senate Appropriations Committee on September 1. The bill would allow a…
AVMA news
House Committee advances AVMA-backed xylazine language
The Administration announced its national coordinated response on July 11 to fight the deadly combination of illicit xylazine mixed with fentanyl.
AVMA news
FDA issues guidance on preventing drug carryover during manufacturing of animal food
The Food and Drug Administration issued guidance that compiles established practices that manufacturers of medicated animal food can use to prevent…
AVMA news
FDA approves generic doramectin topical solution for cattle
The Food and Drug Administration has approved DectoGard, the first generic doramectin topical solution for treatment and control of parasites in…
AVMA news
Midwest Veterinary Supply sentenced to one year probation, pays $11M for misbranded drugs
Minnesota-based drug company Midwest Veterinary Supply recently was sentenced to one year of probation and agreed to pay more than $11 million in…
AVMA news
USDA funds antimicrobial resistance dashboard research
The U.S. Department of Agriculture’s Animal and Plant Health Inspection Service has awarded more than $3.2 million to several universities to develop…
AVMA news
AVMA members press Congress for illicit xylazine, dog importation laws
Nearly 120 veterinarians and veterinary students attended the 2023 AVMA annual legislative fly-in, held April 17-19 in Washington, D.C. They urged…